节点文献

维生素D通过下调谷氨酰胺合成酶抑制乳腺癌细胞增殖

Vitamin D Inhibits Breast Cancer Cell Proliferation by Down- Regulating Glutamine Synthetase

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 袁惠玲吴丽华陈桂林黄珂铭

【Author】 YUAN Huiling;WU Lihua;CHEN Guilin;HUANG Keming;Department of Mastopathy, Dongguan People’s Hospital Affiliated to Southern Medical University;

【机构】 南方医科大学附属东莞人民医院乳腺科

【摘要】 目的 探究维生素D对非三阴性乳腺癌(non-triple negative breast cancer, Non-TNBC)和TNBC癌细胞增殖的影响及分子机制。方法 收集TNBC和Non-TNBC患者乳腺组织,原代培养TNBC和Non-TNBC患者乳腺细胞;免疫荧光检测乳腺细胞雌激素受体(ER)、孕激素受体(PR)和HER2蛋白表达;免疫荧光检测Non-TNBC和TNBC乳腺癌组织和乳腺细胞中VDR蛋白表达;CCK-8检测细胞活力变化;流式细胞术检测细胞增殖和细胞周期的变化;光学比色法检测细胞谷氨酰胺合成酶(glutamine synthetase, GS)活力的变化;ELISA检测细胞培养上清和胞内谷氨酰胺的水平;Western blot检测细胞GS和VDR蛋白表达的变化;CHIP-PCR检测VDR对GS的转录调控。结果 TNBC患者外周血中维生素D水平和癌组织VDR蛋白表达明显低于Non-TNBC患者(P<0.05)。相比于原代Non-TNBC乳腺癌细胞,原代TNBC患者乳腺癌细胞低表达雌激素受体(ER)、孕激素受体(PR)和HER2蛋白表达;TNBC乳腺癌细胞VDR表达水平明显低于Non-TNBC乳腺癌细胞(P<0.05);VD(10-7~10-4mol/L)可明显剂量依赖性的抑制Non-TNBC乳腺癌细胞和TNBC乳腺癌细胞细胞活力(P<0.05)。相比于0mol/L VD组,103mol/L的VD组Non-TNBC乳腺癌细胞和TNBC乳腺癌细胞细胞增殖比例明显减少(P<0.05);相比于0mol/L VD组,103mol/L的VD组Non-TNBC乳腺癌细胞G1/G0期细胞比例明显减少(P<0.05);103mol/L的VD组TNBC乳腺癌细胞G1/G0期细胞比例明显减少,S期细胞比例明显增加(P<0.05);相比于0mol/L VD组,103mol/L的VD组Non-TNBC和TNBC乳腺癌细胞谷氨酰胺合成酶活力、谷氨酰胺合成酶蛋白、细胞内和细胞外谷氨酰胺水平表达比例明显减少(P<0.05);相比于0mol/L VD组,103mol/L的VD组Non-TNBC乳腺癌细胞和TNBC乳腺癌细胞VDR蛋白表达明显增加(P<0.05);103mol/L的VD组TNBC乳腺癌细胞VDR可转录调控GS基因转录(P<0.05)。结论 维生素D通过下调谷氨酰胺合成酶抑制乳腺癌细胞增殖。

【Abstract】 Objective To explore the effect and molecular mechanism of vitamin D(VD) on the proliferation of non-triple negative breast cancer(Non-TNBC) and TNBC cancer cells.Methods We collected breast tissues from patients with TNBC and Non-TNBC, and cultured primary breast cells from patients with TNBC and Non-TNBC; Estrogen receptor(ER), progesterone receptor(PR) and HER2 protein expressions in breast cells immunofluorescence was detected by immunofluorescence; VDR protein expression in Non-TNBC and TNBC breast cancer tissues and breast cells was detected by immunofluorescence; Cell viability was detected by CCK-8 method; Cell proliferation and cell cycle was detected by flow cytometry; Glutamine synthetase(GS) activity was detected by optical colorimetry method; Intracellular and extracellular glutamine were detected by ELISA; GS and VDR protein expressions were detected by western blot; The transcriptional regulation of GS by VDR was detected by CHIP-PCR.Results VD concentration in peripheral blood and the VDR protein expression in cancer tissues of patients with TNBC were significantly lower than those of patients with Non-TNBC(P <0.05); ER, PR, HER2 and VDR protein expressions in breast cancer cells of primary TNBC breast cancer cells were lower than primary Non-TNBC breast cancer cells(P<0.05); VD(10-7-10-4mol/L) could significantly inhibit the cell viability of Non-TNBC breast cancer cells and TNBC breast cancer cells in a dose-dependent manner(P<0.05). Compared with the 0 mol/L VD group, the proliferative proportion of Non-TNBC breast cancer cells and TNBC breast cancer cell in the 103mol/L VD group was significantly reduced(P<0.05); Compared with the 0 mol/L VD group, the proportion of non-TNBC breast cancer cells in the G1/G0 phase of the 103mol/L VD group was significantly reduced(P<0.05); The proportion of TNBC breast cancer cells in the G1/G0 phase of the 103mol/L VD group was significantly reduced, and the proportion of cells in the S phase was significantly increased(P<0.05); Compared with 0 mol/L VD group, Non-TNBC and TNBC breast cancer cell GS activity, GS protein, intracellular and extracellular glutamine content expression ratio of the 103mol/L VD group was significantly reduced(P<0.05); Compared with the 0 mol/L VD group, VDR protein expression of Non-TNBC breast cancer cells and TNBC breast cancer cells in the 103mol/L VD group was significantly increased(P<0.05); 103mol/L The VDR of TNBC breast cancer cells in the VD group could transcriptionally regulate the transcription of GS gene(P<0.05).Conclusion Vitamin D inhibits breast cancer cell proliferation by down-regulating glutamine synthetase.

【基金】 国家自然科学基金项目(编号:81802625);东莞市科技发展重点项目(编号:2018507150011656)
  • 【文献出处】 标记免疫分析与临床 ,Labeled Immunoassays and Clinical Medicine , 编辑部邮箱 ,2022年01期
  • 【分类号】R737.9
  • 【被引频次】1
  • 【下载频次】169
节点文献中: 

本文链接的文献网络图示:

本文的引文网络